The HelpMeSee eye surgery simulator drew high interest.
A recent poll found that most doctors are unfazed by the firm splitting from Novartis.
More than a third of survey respondents indicated plans to adopt the device.
A top item was expanded options for PC-IOLs.
CEO Brent Saunders told analysts in May that the drugmaker already cut its dry eye sales force in early 2018.
The company was founded by Michael Yu, PhD, whose first biotech developed and commercialized conbercept.
Guidelines include statement that commodification in eye banking is not ethically acceptable.
Michael Abramoff, MD, PhD, and two University of Iowa colleagues founded the company in 2010.
Presenters discussed study results for tivanisiran, transcranial neurostimulation, and a compound found in peonies.
The glaucoma surgical device market is expected to grow at a rate of nearly 23 percent over the next five years.
Market Scope’s ‘2018 Cataract Atlas’ provides a geographic analysis of the US cataract market.
Agency says importation may be answer to dramatic price spikes for sole-source off-patent drugs.
Blink currently distributes its products in Europe and the Middle East.
Optos produces and sells ultra-widefield retinal imaging equipment.
Other companies raised $48.7 million, bringing the total for the past month to $93.7 million.
Macregen of California has licensed the technology.
The wet AMD candidate maintained stable vision in over 91 percent of patients on a 12-week regimen.
You are not currently logged in.
©2018 Market Scope
Lost your Password